These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25591980)

  • 1. Leptin levels in Gaucher disease type I patients: A methodological approach.
    Agilli M; Aydin FN; Kurt YG
    Clin Nutr; 2015 Apr; 34(2):328. PubMed ID: 25591980
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Letter to the Editor - Leptin levels in Gaucher disease type I patients: A methodological approach.
    Doneda D; Lopes AL; Teixeira BC; Mittelstadt SD; Moulin CC; Schwartz IV
    Clin Nutr; 2015 Apr; 34(2):329. PubMed ID: 25600498
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease.
    Fujimoto A; Tayebi N; Sidransky E
    Am J Med Genet; 1995 Nov; 59(3):356-8. PubMed ID: 8599361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher disease: lessons from a decade of therapy.
    Grabowski GA
    J Pediatr; 2004 May; 144(5 Suppl):S15-9. PubMed ID: 15126979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gaucher's disease].
    Harzer K
    Med Klin (Munich); 1990 May; 85(5):350. PubMed ID: 2355900
    [No Abstract]   [Full Text] [Related]  

  • 6. [The biochemical diagnosis of Gaucher disease].
    Yargui L; Mokhtari S; Arab M; Berhoune A
    Arch Pediatr; 2005 Aug; 12(8):1301-9. PubMed ID: 15878824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease.
    Holleran WM; Ziegler SG; Goker-Alpan O; Eblan MJ; Elias PM; Schiffmann R; Sidransky E
    Clin Genet; 2006 Apr; 69(4):355-7. PubMed ID: 16630170
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A; Marzouk I; El-Shayeb A; Wali Y
    Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gaucher's disease ].
    Belmatoug N; Caubel I; Stirnemann J; Billette de Villemeur T
    J Soc Biol; 2002; 196(2):141-9. PubMed ID: 12360743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme, substrate, and myeloma in Gaucher disease.
    Hughes DA
    Am J Hematol; 2009 Apr; 84(4):199-201. PubMed ID: 19291728
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gaucher Disease].
    Okuyama T
    Brain Nerve; 2015 Sep; 67(9):1109-13. PubMed ID: 26329151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type 1 Gaucher disease in a pediatric patient: 12 year's evolution].
    García M; Casanova C; Chabás A; Viosca E; Martínez B
    Sangre (Barc); 1997 Jun; 42(3):227-9. PubMed ID: 9381267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT).
    Giona F; Palumbo G; Amendola A; Santoro C; Mazzuconi MG
    J Thromb Haemost; 2006 Aug; 4(8):1831-3. PubMed ID: 16879228
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydrocephalus, corneal opacities, deafness, left ventricle hypertrophy, clinodactyly in an adolescent patient. A new syndrome associated with glucocerebrosidase deficiency.
    Erduran E; Mocan H; Gedik Y; Kamaci R; Okten A; Değer O
    Genet Couns; 1995; 6(3):211-5. PubMed ID: 8588848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologically important mutations: Gaucher disease.
    Beutler E; Gelbart T
    Blood Cells Mol Dis; 1998 Mar; 24(1):2-8. PubMed ID: 9516376
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of Gaucher disease mutations found in Saudi Arabia.
    Kaya N; Al-Zahrani F; Al-Odaib A; Rahbeeni Z; Al-Hassnan Z; Al-Sharif F; Ozand P; Al-Sayed M
    Blood Cells Mol Dis; 2008; 41(2):200-1. PubMed ID: 18586535
    [No Abstract]   [Full Text] [Related]  

  • 17. Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy.
    Mitrovic M; Sumarac Z; Antic D; Bogdanovic A; Elezovic I; Vukosavljevic D; Ignjatovic S; Majkic-Singh N; Suvajdzic N
    Blood Cells Mol Dis; 2012 Jun; 49(1):58-9. PubMed ID: 22459893
    [No Abstract]   [Full Text] [Related]  

  • 18. Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia.
    Langeveld M; Scheij S; Dubbelhuis P; Hollak CE; Sauerwein HP; Simons P; Aerts JM
    Metabolism; 2007 Mar; 56(3):314-9. PubMed ID: 17292718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement therapy in a child with Gaucher disease.
    Masood Y; Ali AS
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):786-8. PubMed ID: 17125641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
    Sobreira E; Pires RF; Cizmarik M; Grabowski GA
    Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.